Euro Results Round-Up: Karo Pharma And Recordati Post Double-Digit Gains
Executive Summary
In the first-half of 2022, Sweden's Karo Pharma saw its sales rise by more than a third thanks to a combination of organic growth and acquisitions. Italy's Recordati reported OTC sales up by almost a fifth as the European market continued to recover post-COVID.
You may also be interested in...
Recordati Makes Good Start to 2022 As Cold & Flu Sales Rebound
Italy's Recordati reports a double-digit rise in OTC sales for the first quarter of 2022, reflecting improved sales of cold & flu products and dietary supplements, particularly in France and its domestic market.
Reckitt Sells Skin-Care Brand E45 To Karo In £200m Deal
Karo Pharma is poised to expand its portfolio in the UK with the acquisition of leading skin-care brand E45 from Reckitt.
Karo Pharma Adds VMS With Deal For Belgium's Sylphar
Sweden's Karo Pharma is acquiring Sylphar Group and its dietary supplement and beauty brands sold around Europe, primarily online.